If you are hoping for a quick sale then the up front money is important. What I'd like to see is a well established (read well capitalized) large Pharm, partner with GTC and in their press statement tout the platform as the driving reason for the partnership. I'm hopeful that in the long term the current compounds will prove profitable, but I believe a public validation by a "substantial" of the platform will move GTC PPS much higher.
Only time will tell. During the conference call it was inferred that they were in discussions with more than one company. Interesting.
Market Data 
Markets 
AI
